-
Something wrong with this record ?
Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors
J. Jakubík, A. Randáková, P. Zimčík, EE. El-Fakahany, V. Doležal,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
Nature Open Access
from 2011-12-01
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
Springer Nature OA/Free Journals
from 2011-12-01
PubMed
28091608
DOI
10.1038/srep40381
Knihovny.cz E-resources
- MeSH
- Models, Biological MeSH
- CHO Cells MeSH
- Cricetulus MeSH
- Kinetics MeSH
- Cricetinae MeSH
- Humans MeSH
- Ligands MeSH
- Mutant Proteins chemistry metabolism MeSH
- N-Methylscopolamine chemistry metabolism MeSH
- Protein Domains MeSH
- Receptors, Muscarinic chemistry metabolism MeSH
- Protein Structure, Secondary MeSH
- Molecular Dynamics Simulation MeSH
- Tritium metabolism MeSH
- Protein Binding MeSH
- Binding Sites MeSH
- Acceleration MeSH
- Animals MeSH
- Check Tag
- Cricetinae MeSH
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Interaction of orthosteric ligands with extracellular domain was described at several aminergic G protein-coupled receptors, including muscarinic acetylcholine receptors. The orthosteric antagonists quinuclidinyl benzilate (QNB) and N-methylscopolamine (NMS) bind to the binding pocket of the muscarinic acetylcholine receptor formed by transmembrane α-helices. We show that high concentrations of either QNB or NMS slow down dissociation of their radiolabeled species from all five subtypes of muscarinic acetylcholine receptors, suggesting allosteric binding. The affinity of NMS at the allosteric site is in the micromolar range for all receptor subtypes. Using molecular modelling of the M2 receptor we found that E172 and E175 in the second extracellular loop and N419 in the third extracellular loop are involved in allosteric binding of NMS. Mutation of these amino acids to alanine decreased affinity of NMS for the allosteric binding site confirming results of molecular modelling. The allosteric binding site of NMS overlaps with the binding site of some allosteric, ectopic and bitopic ligands. Understanding of interactions of NMS at the allosteric binding site is essential for correct analysis of binding and action of these ligands.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19001338
- 003
- CZ-PrNML
- 005
- 20190108130326.0
- 007
- ta
- 008
- 190107s2017 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/srep40381 $2 doi
- 035 __
- $a (PubMed)28091608
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Jakubík, Jan $u Institute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
- 245 10
- $a Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors / $c J. Jakubík, A. Randáková, P. Zimčík, EE. El-Fakahany, V. Doležal,
- 520 9_
- $a Interaction of orthosteric ligands with extracellular domain was described at several aminergic G protein-coupled receptors, including muscarinic acetylcholine receptors. The orthosteric antagonists quinuclidinyl benzilate (QNB) and N-methylscopolamine (NMS) bind to the binding pocket of the muscarinic acetylcholine receptor formed by transmembrane α-helices. We show that high concentrations of either QNB or NMS slow down dissociation of their radiolabeled species from all five subtypes of muscarinic acetylcholine receptors, suggesting allosteric binding. The affinity of NMS at the allosteric site is in the micromolar range for all receptor subtypes. Using molecular modelling of the M2 receptor we found that E172 and E175 in the second extracellular loop and N419 in the third extracellular loop are involved in allosteric binding of NMS. Mutation of these amino acids to alanine decreased affinity of NMS for the allosteric binding site confirming results of molecular modelling. The allosteric binding site of NMS overlaps with the binding site of some allosteric, ectopic and bitopic ligands. Understanding of interactions of NMS at the allosteric binding site is essential for correct analysis of binding and action of these ligands.
- 650 _2
- $a zrychlení $7 D000054
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a CHO buňky $7 D016466
- 650 _2
- $a křečci praví $7 D006224
- 650 _2
- $a Cricetulus $7 D003412
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a mutantní proteiny $x chemie $x metabolismus $7 D050505
- 650 _2
- $a N-methylskopolamin $x chemie $x metabolismus $7 D019832
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a sekundární struktura proteinů $7 D017433
- 650 _2
- $a receptory muskarinové $x chemie $x metabolismus $7 D011976
- 650 _2
- $a tritium $x metabolismus $7 D014316
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Randáková, Alena $u Institute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
- 700 1_
- $a Zimčík, Pavel $u Institute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
- 700 1_
- $a El-Fakahany, Esam E $u Department of Experimental and Clinical Pharmacology, University of Minnesota College of Pharmacy, Minneapolis, MN 55455, USA (EEE).
- 700 1_
- $a Doležal, Vladimír $u Institute of Physiology, Czech Academy of Sciences, 14220 Prague, Czech Republic.
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 7, č. - (2017), s. 40381
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28091608 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20190108130527 $b ABA008
- 999 __
- $a ok $b bmc $g 1365218 $s 1039461
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 7 $c - $d 40381 $e 20170116 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20190107